Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a daily supplement boost fertility? a new trial investigates

NCT ID NCT07740187

Disease control Sponsor: WeNatal Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 31, 2026 · Last updated Jul 31, 2026

Summary

This trial tests whether a daily dietary supplement called WeNatal For Her can improve markers of female fertility in women who are trying to conceive. Forty women aged 18-45 will take three capsules each morning for three menstrual cycles. Researchers will measure blood levels of hormones and other fertility-related markers, and track self-reported changes in energy, mood, and reproductive health.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
WeNatal For Her supplement (dietary supplement)
What this could lead to
If the supplement improves fertility-related blood markers, it could offer a natural option to support reproductive health in women trying to conceive.
What could go wrong
This is a small, early-stage trial without a placebo group, so results may not be conclusive. The supplement may not change fertility markers or improve chances of conception.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

40 people

The number who actually took part.

Started

Apr 2025

Finished

Feb 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Be female. * Be aged 18-45. * In the past three menstrual cycles, has experienced issues with all of the following: Low energy levels and fatigue * Bloating * Breast tenderness * Irritability or mood swings. * Currently trying to conceive. * Anyone who is generally healthy - does not live with any uncontrolled chronic disease. * Not planning on introducing any products or any new forms of prescription medication or supplements that target female fertility for the study duration. * Has a regular menstrual cycle between 21 and 35 days in length and is able to predict the dates of their upcoming periods. * Resides in the United States. * Not currently partaking in another research study and will not be partaking in any other research study for the next three menstrual cycles and at any point during this study's duration. * Willing to avoid all other prenatal vitamins for the duration of this study. Exclusion Criteria: * Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders. * Anyone with any allergies or sensitivities to any of the study product ingredients. * Any women who are currently pregnant or breastfeeding. * Anyone taking anticoagulant or "blood thinning" medication. * Anyone taking bisphosphonates or other prescription medications for osteoporosis. * Anyone taking chemotherapy medication. * Anyone diagnosed with hemochromatosis or elevated iron levels. * Anyone who drinks heavily (i.e. eight or more alcoholic drinks per week for women or 15 or more alcoholic drinks per week for men). * Anyone unwilling to follow the study protocol. * Anyone with a history of substance abuse. * Anyone who is currently a smoker or has been a smoker in the past three months. * Anyone who has stopped using hormonal birth control less than six months prior to starting the study. * Anyone previously diagnosed with premenstrual dysphoric disorder (PMDD), endometriosis, or any cancer of the reproductive system. * Anyone who is peri- or post-menopausal.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Female infertility are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

female infertility

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Female infertility Fertility Hormonal imbalance Ovarian reserve Reproductive health

Contacts and locations

Locations

  • Citruslabs

    Las Vegas, Nevada, 89118, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.